Fortress Biotech (FBIOP) Institutional Ownership → Nvidia CEO Says It Will Be “the Next Revolution” Beyond AI (From Banyan Hill Publishing) (Ad) Free FBIOP Stock Alerts $14.81 +0.99 (+7.16%) (As of 04/29/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Fortress Biotech (NASDAQ:FBIOP)Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$655.88K Get FBIOP Insider Trade Alerts Want to know when executives and insiders are buying or selling Fortress Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Unstoppable ProsperityCharles Payne’s Gift to Stock InvestorsRight now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.Watch Insider's Advantage Event Tuesday at 4:00 PM ET Fortress Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/20/2023 Shikiar Asset Management Inc.15,000$262K0.1%-71.4%0.000% 4/20/2023 Shikiar Asset Management Inc.52,500$966K0.3%N/A0.000% 10/25/2022 Shikiar Asset Management Inc.62,000$1.16M0.5%-17.3%0.000% (Data available from 1/1/2016 forward) FBIOP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FBIOP shares? During the previous two years, the following institutional investors and hedge funds held shares of Fortress Biotech shares: Shikiar Asset Management Inc. ($262K).Learn more on FBIOP's institutional investors. Which institutional investors have been buying Fortress Biotech stock? The following institutional investors have purchased Fortress Biotech stock in the last 24 months: Shikiar Asset Management Inc. ($52.50K). How much institutional buying is happening at Fortress Biotech? Institutional investors have bought a total of 52,500 shares in the last 24 months. This purchase volume represents approximately $966.00K in transactions. Which Fortress Biotech major shareholders have been selling company stock? The following institutional investors have sold Fortress Biotech stock in the last 24 months: Shikiar Asset Management Inc. ($50.50K). How much institutional selling is happening at Fortress Biotech? Institutional investors have sold a total of 50,500 shares in the last 24 months. This volume of shares sold represents approximately $655.88K in transactions. Related Companies: Alpha Tau Medical Major Shareholders Apollomics Major Shareholders BriaCell Therapeutics Major Shareholders Cardio Diagnostics Major Shareholders Celularity Major Shareholders Humacyte Major Shareholders Immatics Major Shareholders Jasper Therapeutics Major Shareholders NewAmsterdam Pharma Major Shareholders Ocean Biomedical Major Shareholders This page (NASDAQ:FBIOP) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityHe Is Giving Away BitcoinCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
